Published in

Wiley, European Journal of Immunology, 3(29), p. 912-917, 1999

DOI: 10.1002/(sici)1521-4141(199903)29:03<912::aid-immu912>3.0.co;2-g

Wiley, European Journal of Immunology, 03(29), p. 912-917

DOI: 10.1002/(sici)1521-4141(199903)29:03<912::aid-immu912>3.3.co;2-7

Links

Tools

Export citation

Search in Google Scholar

A tumor necrosis factor‐induced model of human primary demyelinating diseases develops in immunodeficient mice

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We have reported previously that in the central nervous system (CNS) local expression of tumor necrosis factor (TNF) transgenes can trigger the development of oligodendrocyte apoptosis, primary inflammatory demyelination and neurological dysfunction, accompanied by lymphocyte and macrophage infiltration into the CNS. To distinguish between the local effects of transgene-encoded TNF and the potential encephalitogenic effects of immune infiltrates upon CNS disease pathogenesis, we have backcrossed Tg6074 TNF-transgenic mice to mice deficient in CD4, β2-microglobulin (β2m), immunoglobulin μ  chain (Igμ ) or recombination activation gene-1 (Rag-1). TNF was capable of triggering undiminished primary demyelination in all of the immunodeficient mice, in the presence of activated cells of the macrophage / microglial lineage. We conclude that TNF is sufficient to induce primary inflammatory demyelination and neurological deficits even in the absence of adaptive immunity.